Bioptik Technology (4161) — Financial Flexibility Index
Bioptik Technology (4161) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of NT$58.15 Million (operating CF NT$53.21 Million minus capex NT$4.94 Million) represents 0% of total liabilities (NT$597.14 Million). Also explore Bioptik Technology equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bioptik Technology Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Bioptik Technology across 9 annual periods. Check strategic asset allocation of Bioptik Technology to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Bioptik Technology (2017–2025)
Year-by-year free cash flow to debt coverage for Bioptik Technology. For the full company profile including market capitalisation, see market value of Bioptik Technology.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | NT$82.79 Million | NT$59.99 Million | NT$597.14 Million | ▼ -53.7% |
| 2024 | 0.30x | NT$174.33 Million | NT$158.82 Million | NT$582.47 Million | ▼ -14.9% |
| 2023 | 0.35x | NT$236.99 Million | NT$205.95 Million | NT$673.56 Million | ▲ +288.9% |
| 2022 | 0.09x | NT$72.14 Million | NT$55.06 Million | NT$797.40 Million | ▲ +451.8% |
| 2021 | -0.03x | NT$-21.33 Million | NT$-41.15 Million | NT$829.38 Million | ▼ -196.1% |
| 2020 | 0.03x | NT$19.75 Million | NT$6.57 Million | NT$738.10 Million | ▼ -69.3% |
| 2019 | 0.09x | NT$68.46 Million | NT$41.03 Million | NT$786.05 Million | ▼ -25.7% |
| 2018 | 0.12x | NT$92.78 Million | NT$41.83 Million | NT$792.07 Million | ▲ +7.7% |
| 2017 | 0.11x | NT$73.74 Million | NT$11.02 Million | NT$678.08 Million | — |